Industry Bulletins | June 22, 2022
English National Institute For Health & Care Excellence Recommends Sleepio Digital Therapeutic For Treating Insomnia
The English National Institute for Health and Care Excellence (NICE) recommended Sleepio, a digital therapeutic, as a cost-saving option for treating insomnia. Sleepio, developed by Big Health, is the first ever digital therapeutics company to receive NICE guidance. The NICE guidance states that Sleepio is a safe and effective treatment for people who would otherwise only have access to the current standard of care, which includes sleep hygiene advice and medication.
The NICE guidance also confirms Sleepio as cost-saving option for the National Health Service (NHS). The evidence shows that Sleepio reduces general practitioner appointments and prescribing costs . . .